How is the Synaptogenix Inc today?

The Synaptogenix Inc today is trading in the down by -23.66% at 3.71.

How has Synaptogenix Inc performed historically?

The Synaptogenix Inc is currently trading down -23.66% on an intraday basis in the past week the index rose 53.94%. The index has been up 27.93% in the past quarter and fell -15.10% in the past year. You can view this in the overview section.

What is Synaptogenix Inc Annual Net Profit?

Synaptogenix Inc Annual Net Profit fell 111.45% in the last year to $12.77 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Synaptogenix Inc Price to Earning Ratio?

Synaptogenix Inc Price to Earning Ratio is -0.42, which is negative.

What is Synaptogenix Inc Stock Price?

Synaptogenix Inc Stock Price fell 15.1% and underperformed its sector by 39.91% in the past year.

What is Synaptogenix Inc Quarterly Net profit?

Synaptogenix Inc Quarterly Net profit rose 286.34% YoY to $0.39 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is Synaptogenix Inc Return on Equity(ROE)?

Synaptogenix Inc Return on Equity(ROE) for the last financial year was -89.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Synaptogenix Inc Mutual Fund Holding?

Synaptogenix Inc Mutual Fund Holding increased by 0.01% in the last quarter to 1.25.

What is Synaptogenix Inc Institutional Holding?

Synaptogenix Inc Institutional Holding increased by 2.03% in the last quarter to 5.4.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
SYNAPTOGENIX INC

Synaptogenix Inc XNAS: SNPX

Synaptogenix Inc Live Share Price Today, Share Analysis and Chart

Name: Synaptogenix Inc: Is Infosys Ltd. worth buying?
Item: Synaptogenix Inc
Rating: 1.76783325
Author: Trendlyne DVM scores

about

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer'...

3.71 -1.15 (-23.66%)

New 52W High in past week

454.5K

XNAS Volume

High vol.+gain this week

XNAS 13 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.8 / 100

Technically Neutral

58.9 / 100

No estimates available

Synaptogenix Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Synaptogenix Inc Live Share Price Today, Share Analysis and Chart

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer'...

New 52W High in past week

High vol.+gain this week

SWOT Analysis

Synaptogenix Inc Live Price Chart

Synaptogenix Inc FAQ

How is Synaptogenix Inc today?

Synaptogenix Inc today is trading in the red, and is down by -23.66% at 3.71.

How has Synaptogenix Inc performed historically?

Synaptogenix Inc is currently trading down -23.66% on an intraday basis. In the past week the stock rose 53.94%. stock has been up 27.93% in the past quarter and fell -15.10% in the past year. You can view this in the overview section.